Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.

INTRODUCTION AND OBJECTIVES: An exaggerated accumulation of type I and type III fibrillar collagens occurs throughout the free wall and interventricular septum of patients with primary hypertension and left ventricular hypertrophy (LVH). In the present study the serum concentration of procollagen type III amino terminal peptide (PIIIP) was measured to determine the value of this peptide as a potential marker of ventricular fibrosis in hypertensive patients, particularly those with LVH. METHODS: The study population consisted of patients with never-treated mild to moderate essential hypertension and 30 normotensive control subjects. Clinical, echocardiographic, electrocardiographic and biochemical parameters were assessed in all patients. RESULTS: Heart rate, body mass index and levels of blood pressure were increased in hypertensives, particularly those with LVH, compared to normotensive controls. Posterior wall thickness, left ventricular (LV) mass and LV mass index, and serum PIIIP concentration were also increased in hypertensives, with significant differences between the two hypertensive groups. The ratio between maximal early and late transmitral flow velocity measured during diastole was lower in hypertensives, particularly those with LVH, than in normotensive controls. CONCLUSIONS: The increase in PIIIP indicates that type III collagen synthesis increases in hypertensives, particularly those with LVH, implying that alterations in the heart in hypertension are the result not solely of hypertrophied LV muscle, but also of increased collagen deposition within the ventricular wall and around the coronary vessels. Thus, measurement of serum PIIIP could be a practical and useful tool in the non-invasive assessment of myocardial remodeling in hypertension.

Prevalence, awareness, treatment and control of hypertension in Portugal. The PAP study.

The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the level of awareness, treatment, and control of hypertension in the Portuguese adult population. The study was conducted in 2003, using a multistage cluster sampling method to select a representative national sample. A total of 5023 adults, aged 18 to 90 years, were examined. Three blood pressure measurements were obtained by trained observers using an OMRON M4-1 sphygmomanometer after a 5-minute seated rest. Information on history of hypertension and use of antihypertensive medication was obtained using a standard questionnaire. Hypertension was defined as mean systolic blood pressure > or =140 mmHg and/or diastolic blood pressure > or =90 mmHg, or use of antihypertensive medication. Overall, 42.1% of the Portuguese adult population aged 18 to 90 years, representing 3,311,830 people, would have hypertension. The age-specific prevalence of hypertension in the three age-groups studied--under 35 years, 35-64 years, and over 64 years--was 26.2%, 54.7% and 79% in men and 12.4%, 41.1% and 78.7% in women respectively. Among hypertensive subjects, only 46.1% were aware of their high blood pressure, 39.0% were taking antihypertensive medication, and 11.2% had their blood pressure controlled (<140/90 mmHg). Our results indicate that hypertension is highly prevalent in Portugal. The percentages of hypertensives who are aware of their condition, are being treated, and whose hypertension is controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of hypertension in Portugal.

Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study.

BACKGROUND: The objective of this study was to estimate the prevalence and distribution of hypertension and to determine the status of hypertension awareness, treatment and control in the Portuguese adult population. METHODS: This study was conducted in 2003, and a multistage cluster sampling method was used to select a national representative sample. A total of 5023 adults, age 18-90 years, were examined. Three blood pressure measurements were obtained by trained observers using an OMROM M4-I sphygmomanometer after a 5-min sitting rest. Information on the history of hypertension and the use of antihypertensive medications was obtained by use of a standard questionnaire. RESULTS: Hypertension was defined as a mean systolic blood pressure > or = 140 mmHg and/or diastolic blood pressure > or = 90 mmHg, or the use of antihypertensive medications. Overall, 42.1% of the Portuguese adult population aged 18-90 years, representing 3 311 830 people, had hypertension. The age-specific prevalence of hypertension in the three age groups studied--younger than 35 years, 35-64 years old and older than 64 years--was 26.2, 54.7 and 79% in men and 12.4, 41.1 and 78.7% in women, respectively. Among hypertensive patients, only 46.1% were aware of their high blood pressure, 39.0% were taking antihypertensive medication and 11.2% achieved blood pressure control (< 140/90 mmHg). CONCLUSIONS: Our results indicate that hypertension is highly prevalent in Portugal. The percentages of those with hypertension that are aware, treated and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection and treatment of hypertension in Portugal.